B. Igau
Pasteur Institute
6 Papers
45 Citations
B. Igau is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Apolipoprotein B & Cholesterol. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
In Vivo Glucosylated LpA-I Subfraction Evidence for Structural and Functional Alterations
B. Igau,Graciela Castro,Véronique Clavey,Christian Slomianny,Régis Bresson,Pierre Drouin,Jean-Charles Fruchart,Catherine Fievet +7 more
TL;DR: Cell culture data suggest that nonenzymatic glycosylation occurring on apo A-I can modify lipoprotein function, since it results in a decreased binding of GLpA-I to HeLa cells and impaired cholesterol efflux from Fu5AH rat hepatoma cells.
14
•Journal Article
Non-enzymatic glycosylation of apolipoprotein A-I and its functional consequences.
TL;DR: This study considers the different impacts of non-enzymatic glycosylation of apo A-I or protein-HDL on the reverse cholesterol transport process.
12
Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients
TL;DR: It is suggested that IP insulin delivery may be a more physiological route that increases the choline-containing PL content of LpB particles and not linked to changes in blood glucose control, body weight or daily insulin requirements.
7
•Journal Article
Accessibility of human apolipoprotein B-100 epitopes in insulin-dependent diabetes: relation with the surface lipid environment of atherogenic particles.
TL;DR: It is concluded that subtle abnormalities in the composition and conformation of atherogenic apo-B-containing lipoproteins occur in Type 1 diabetes mellitus, and these structural modifications may be one factor accounting for the increased rate of atherosclerosis in diabetes.
7
Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes.
B. Igau,Sophie Lestavel,Véronique Clavey,Christian Slomianny,Pierre Drouin,Régis Bresson,Jean-Charles Fruchart,Patrick Duriez,Catherine Fievet +8 more
TL;DR: This study shows that IDDM is not associated with any significant abnormalities in the apo-containing lipoprotein particles, and the excessive occurrence of coronary heart disease (CHD) and other atherosclerotic vascular disease in patients with IDDM must have other causes.
5